CRH Medical Corp (CRH) Given New C$6.75 Price Target at Scotiabank
CRH has been the subject of several other research reports. TD Securities decreased their target price on CRH Medical Corp from C$12.00 to C$10.50 and set a buy rating for the company in a research report on Friday, July 7th. Royal Bank Of Canada decreased their target price on CRH Medical Corp from C$8.50 to C$6.00 and set an outperform rating for the company in a research report on Friday, July 21st. National Bank Financial decreased their target price on CRH Medical Corp from C$9.00 to C$7.00 in a research report on Monday, July 17th. Finally, Bloom Burton lowered CRH Medical Corp from a buy rating to an accumulate rating in a research report on Friday, July 14th. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock presently has an average rating of Buy and a consensus target price of C$6.75.
Shares of CRH Medical Corp (CRH) opened at 3.14 on Thursday. The firm has a 50-day moving average price of $6.16 and a 200-day moving average price of $8.46. CRH Medical Corp has a 52 week low of $3.10 and a 52 week high of $12.35. The stock has a market cap of $232.11 million and a PE ratio of 25.74.
In related news, Director David Johnson sold 30,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 28th. The stock was sold at an average price of C$5.67, for a total transaction of C$170,100.00.
About CRH Medical Corp
CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.
Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.